-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's Intraday Session
Share
Listen to the news

Gainers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million.
  • Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 21.19% to $2.63. The company's market cap stands at $1.5 million.
  • Xtant Medical Holdings (AMEX:XTNT) shares increased by 15.93% to $0.38. The market value of their outstanding shares is at $46.2 million.
  • Femasys (NASDAQ:FEMY) stock increased by 15.23% to $3.21. The company's market cap stands at $23.3 million.
  • Rafael Holdings (NYSE:RFL) shares moved upwards by 12.57% to $2.67. The market value of their outstanding shares is at $123.2 million.
  • Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock moved upwards by 8.9% to $0.12.

Losers

  • BioXcel Therapeutics (NASDAQ:BTAI) shares decreased by 76.5% to $0.17 during Friday's regular session. The market value of their outstanding shares is at $22.5 million.
  • BioAtla (NASDAQ:BCAB) stock fell 45.55% to $1.71. The company's market cap stands at $5.2 million.
  • Propanc Biopharma (NASDAQ:PPCB) shares fell 40.81% to $1.32. The market value of their outstanding shares is at $5.0 million.
  • Profusa (NASDAQ:PFSA) shares decreased by 29.13% to $3.0. The company's market cap stands at $2.5 million.
  • Celularity (NASDAQ:CELU) shares declined by 26.2% to $1.55. The market value of their outstanding shares is at $59.8 million.
  • Beyond Air (NASDAQ:XAIR) stock declined by 18.6% to $4.64. The company's market cap stands at $5.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending